The aim of the study was to investigate the acute effect of GH per se, independent from its lipolytic activity, on glucose and lipid oxidation and glucose turnover in seven healthy subjects. Five tests lasting 360 min were performed. Each test consisted of a 4-h equilibration period followed by a euglycemic hyperinsulinemic (25 mU/ kg⅐h) clamp lasting 2 h. In test 1 (control experiment) saline was infused, leaving GH and FFA at basal levels. In tests 2, 3, and 4, GH was infused (80 ng/kg⅐min) to increase GH levels. Whereas in test 2 FFA levels were free to increase due to GH lipolytic activity, in test 3 FFA elevation was prevented by using an antilipolytic compound (Acipimox) that allowed evaluation of the effect of GH at low FFA levels. In test 4 (GHϩAcipimoxϩheparin) GH infusion was associated with the administration of Acipimox and heparin to maintain FFA at the basal level to evaluate the effect of GH per se independent from GH lipolytic activity. In test 5 Acipimox and a variable heparin infusion were given to evaluate possible effects of Acipimox other than the inhibition of lipolysis.During the euglycemic hyperinsulinemic clamp in the presence of high GH and FFA levels (test 2), glucose oxidation was significantly lower and lipid oxidation was significantly higher than in tests 1, 3, 4, and 5. During the same period, hepatic glucose production was completely suppressed in the control study (test 1; 94%) and in test 5 (99.6%), whereas it was significantly less inhibited (65%, 74%, and 73%) when GH was administered in tests 2, 3, and 4.In conclusion, these results suggest that GH directly mediates the reduction of insulin's effect on the liver. In addition, the effect of GH on glucose and lipid oxidation is not direct, but is mediated by its lipolytic activity. (J Clin Endocrinol Metab 84: 1658 -1663, 1999) M ANY STUDIES have shown that GH can induce insulin resistance (1-3), although the mechanism by which an acute increase in its levels can decrease glucose uptake is still debated. In vitro studies have shown that GH decreases glucose uptake without affecting glucose oxidation in human erythrocytes (4, 5), fat tissue (6), or diaphragm cultures (7). In vivo, hepatic glucose seems to reduce forearm glucose uptake, glucose oxidation, and glycogen synthase activity and to impair insulin suppression of hepatic glucose production (8 -10) in favor of increased lipid oxidation. Recently, Neely et al. (11) have shown that after an overnight GH infusion in normal subjects, both GH and free fatty acid (FFA) levels were positively correlated with the increase in peripheral and hepatic insulin resistance. In addition, in most of the previous studies, high levels of GH were invariably associated with high circulating levels of glycerol, FFA, and -hydroxybutyrate (8 -10, 12, 13). Therefore, it remains unclear whether the effect of GH on glucose metabolism is direct (10) or mediated by GH-induced lipolytic action through the well known glucose-fatty acid cycle or Randle cycle, as hypothesized by Davidson et...